About Kura Oncology
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.
Leadership at Kura Oncology
The team at the top of the org chart.
Troy Wilson
President & CEO
196 reports
Amaya Gascó
Vice President Clinical Development And Global Medical Affairs
74 reports
Brian Powl
Chief Commercial Officer
41 reports
Kathleen Ford
Chief Operating Officer
22 reports
Francis Burrows
Chief Scientific Officer
12 reports
Tom Doyle
SVP, Finance & Accounting
10 reports
Matt Kelly
Vice President, Regulatory Affairs
5 reports
Mollie Leoni
Chief Medical Officer
4 reports
Kelly Cannan- Kennerly
Vice President, Human Resources
4 reports
Board
Mary Szela
Director
Diane Parks
Board Of Directors
Helen Collins
Director
Carol Schafer
Director
Michael Vasconcelles
Director
Faheem Hasnain
Director
Open Jobs at Kura Oncology (7)
- Kura Oncology · Los Angeles, CA · 12d$210k – $230k
- Kura Oncology · Albany · 19d$210k – $230k
- Kura Oncology · Boston, MA · 1mo$294k – $341k
- Kura Oncology · Boston, MA · 1mo$87k – $102k
- Kura Oncology · San Diego, CA · 1mo$235k – $263k
- Kura Oncology · Boston, MA or Remote · 2mo$160k – $187k
- Kura Oncology · Remote · 2mo$205k – $230k